Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022

SELL
$9.82 - $12.44 $491,982 - $623,244
-50,100 Closed
0 $0
Q3 2021

Nov 09, 2021

BUY
$8.74 - $11.84 $141,588 - $191,808
16,200 Added 47.79%
50,100 $478,000
Q2 2021

Aug 11, 2021

BUY
$8.71 - $10.72 $295,269 - $363,408
33,900 New
33,900 $315,000
Q4 2018

Feb 01, 2019

SELL
$8.38 - $13.44 $383,544 - $615,135
-45,769 Closed
0 $0
Q3 2018

Nov 01, 2018

SELL
$11.6 - $16.54 $921,712 - $1.31 Million
-79,458 Reduced 63.45%
45,769 $553,000
Q2 2018

Jul 31, 2018

BUY
$13.13 - $17.09 $208,767 - $271,731
15,900 Added 14.54%
125,227 $1.96 Million
Q1 2018

May 11, 2018

SELL
$13.76 - $17.12 $1.49 Million - $1.86 Million
-108,427 Reduced 49.79%
109,327 $1.64 Million
Q4 2017

Feb 02, 2018

SELL
$12.51 - $16.24 $96,327 - $125,047
-7,700 Reduced 3.42%
217,754 $3.13 Million
Q3 2017

Nov 09, 2017

BUY
$11.74 - $15.78 $2.65 Million - $3.56 Million
225,454
225,454 $3.4 Million

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.56B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.